Needham & Company LLC Begins Coverage on Artiva Biotherapeutics (NASDAQ:ARTV)
Needham & Company LLC began coverage on shares of Artiva Biotherapeutics (NASDAQ:ARTV – Free Report) in a research note published on Tuesday morning, MarketBeat.com reports. The brokerage issued a buy rating and a $23.00 target price on the stock. Artiva Biotherapeutics Trading Down 0.6 % Artiva Biotherapeutics stock opened at $11.36 on Tuesday. Artiva Biotherapeutics […]
More Stories
Avnet (AVT) to Release Earnings on Wednesday
Avnet (NASDAQ:AVT – Get Free Report) is projected to issue its quarterly earnings data before the market opens on Wednesday,...
PTC (PTC) Expected to Announce Earnings on Wednesday
PTC (NASDAQ:PTC – Get Free Report) is expected to issue its quarterly earnings data before the market opens on Wednesday,...
Markel Group (MKL) Projected to Post Earnings on Wednesday
Markel Group (NYSE:MKL – Get Free Report) is expected to be posting its quarterly earnings results after the market closes...
Phoenix New Media (NYSE:FENG) Earns Hold Rating from Analysts at StockNews.com
StockNews.com started coverage on shares of Phoenix New Media (NYSE:FENG – Free Report) in a research report released on Saturday....
Ampio Pharmaceuticals (NYSE:AMPE) Coverage Initiated at StockNews.com
StockNews.com assumed coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Get Free Report) in a research note issued on Sunday....
Flexible Solutions International (NYSE:FSI) Earns Hold Rating from Analysts at StockNews.com
StockNews.com assumed coverage on shares of Flexible Solutions International (NYSE:FSI – Free Report) in a report issued on Saturday. The...